| Rhode Island Audiology & Hearing Aid Centers, Inc. | |
|
1395 Atwood Ave Ste 104, Johnston, RI 02919-4930 | |
| (401) 946-4660 | |
| (401) 946-0020 |
| Full Name | Rhode Island Audiology & Hearing Aid Centers, Inc. |
|---|---|
| Type | Facility |
| Speciality | Audiologist - Assistive Technology Practitioner |
| Location | 1395 Atwood Ave Ste 104, Johnston, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457121709 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231HA2400X | Audiologist - Assistive Technology Practitioner | (* (Not Available)) | Primary |
| Provider Name | James Edward Mccann |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1114044641 PECOS PAC ID: 1951751304 Enrollment ID: I20240129004408 |
News Archive
MediConnect Global Inc. today announced that the company has been selected as a finalist for Red Herring's North America 100 award, which honors the year's most promising private technology ventures in North America.
Many biopharmaceuticals comprise small proteins that are quickly eliminated from the body. Scientists at the Technische Universitaet Muenchen (TUM) combine such small proteins with a kind of molecular balloon that swells and thus prolongs the half-life of the proteins in the body. The TUM spin-off XL-Protein GmbH has now started to further develop this new technology with blockbuster potential.
Breast Cancer Action - respected watchdog of the breast cancer movement - is calling out money-making giants KFC and Susan G. Komen for the Cure for their egregious pinkwashing campaign "Buckets for the Cure." This partnership exploits breast cancer and does the most harm in low income communities already disproportionately affected by health issues like obesity, diabetes, as well as breast cancer.
University of Alberta computing scientists are developing an app to aid health-care staff to assess and manage pain in patients suffering from dementia and other neurodegenerative diseases.
The Michael J. Fox Foundation for Parkinson's Research today announced nearly $1.1 million for projects aimed at advancing the development of leading biomarker candidates for Parkinson's disease. The discovery and validation of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development, allowing scientists and clinicians to more accurately identify appropriate subjects for clinical studies, measure disease progression and monitor treatment effects in clinical trials.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rhode Island Audiology & Hearing Aid Centers, Inc. 1395 Atwood Ave Ste 104, Johnston, RI 02919-4930 Ph: (401) 946-4660 | Rhode Island Audiology & Hearing Aid Centers, Inc. 1395 Atwood Ave Ste 104, Johnston, RI 02919-4930 Ph: (401) 946-4660 |
News Archive
MediConnect Global Inc. today announced that the company has been selected as a finalist for Red Herring's North America 100 award, which honors the year's most promising private technology ventures in North America.
Many biopharmaceuticals comprise small proteins that are quickly eliminated from the body. Scientists at the Technische Universitaet Muenchen (TUM) combine such small proteins with a kind of molecular balloon that swells and thus prolongs the half-life of the proteins in the body. The TUM spin-off XL-Protein GmbH has now started to further develop this new technology with blockbuster potential.
Breast Cancer Action - respected watchdog of the breast cancer movement - is calling out money-making giants KFC and Susan G. Komen for the Cure for their egregious pinkwashing campaign "Buckets for the Cure." This partnership exploits breast cancer and does the most harm in low income communities already disproportionately affected by health issues like obesity, diabetes, as well as breast cancer.
University of Alberta computing scientists are developing an app to aid health-care staff to assess and manage pain in patients suffering from dementia and other neurodegenerative diseases.
The Michael J. Fox Foundation for Parkinson's Research today announced nearly $1.1 million for projects aimed at advancing the development of leading biomarker candidates for Parkinson's disease. The discovery and validation of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development, allowing scientists and clinicians to more accurately identify appropriate subjects for clinical studies, measure disease progression and monitor treatment effects in clinical trials.
› Verified 6 days ago
Mr. James Edward Mccann Jr., MSC. AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1395 Atwood Ave, Suite 104, Johnston, RI 02919 Phone: 401-946-4660 Fax: 401-946-0020 |